期刊論文1. | Johnson, D. H.、Cunha, B. A.(1996)。Drug fever。Infect Dis Clin North Am,10,85-91。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
2. | Roush MK、Nelson KM.(1993)。Understanding drug-induced febrile reactions。Am Pharm,NS33,39-42。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
3. | Tabor PA.(1986)。Drug-induced fever。Drug Intell Clin Pharm,20,413-420。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
4. | Mackowiak PA、LeMaistre CF.(1987)。Drug fever: a critical appraisal of conventional concepts. An analysis of 51 episodes in two Dallas hospitals and 97 episodes reported in the English literature。Ann Intern Med,106,728-733。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
5. | Kaul DR、Flanders SA、Beck JM、Saint S.(2006)。Brief report: incidence, etiology, risk factors, and outcome of hospital-acquired fever: a systematic, evidence-based review。J Gen Intern Med,21,1184-1187。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
6. | Mackowiak PA.(1987)。Drug fever: mechanisms, maxims and misconceptions。Am J Med Sei,294,275-286。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
7. | (1988)。Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group。J Antimicrob Chemother,22,221-228。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
8. | Lipsky BA、Hirschmann JV.(1981)。Drug fever。JAMA,245,851-854。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
9. | Gattoni F、Comalba G.、Brambilla G、Dova S、Pompili G、Rampoldi A(1998)。Survival of 184 patients with hepatocellular carcinoma in cirrhotic liver treated with chemoembolization. A multicenter study。Radiol Med (Torino),95,362-368。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
10. | Rose DM、Chapman WC、Brockenbrough AT、Wright Jk、Rose AT、Meranze S(1999)。Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma。Am J Surg,177,405-410。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
11. | Thalheimer U、Triantos CK、Samonakis DN、Patch D、Burroughs AK(2005)。Infection, coagulation, and variceal bleeding in cirrhosis。Gut,54,556-563。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
12. | Liu K、He X、Lei XZ、Zhao LS、Tang H、Liu L(2003)。Pathomorphological study on location and distribution of Kupffer cells in hepatocellular carcinoma。World J Gastroenterol,9,1946-1949。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
13. | Montay G、Gaillot J.(1990)。Pharmacokinetics of fluoroquinolones in hepatic failure。J Antimicrob Chemother,26 Suppl,61-67。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
14. | Wittesjo B、Bjornham A、Eitrem R(1999)。Relative bradycardia in infectious diseases。J Infect,39,246-247。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
15. | Hanson MA.(1991)。Drug fever. Remember to consider it in diagnosis。Postgrad Med,89,167-170。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
16. | Cuddy, ML.(2004)。The effects of drugs on thermoregulation。AACN Clin Issues,15,238-253。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
17. | Kubin R.(1993)。Safety and efficacy of ciprofloxacin in paediatric patients-review。Infection,21,413-421。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
18. | Hampel, B、Hullmann, R、Schmidt, H.(1997)。Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use--safety report。Pediatr Infect Dis J,16,127-129。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
19. | Naranjo, C. A.、Busto, U.、Sellers, E. M.、Sandor, P.、Ruiz, I.、Roberts, E. A.、Janecek, E.、Domecq, C.、Greenblatt, D. J.(1981)。A method for estimating the probability of adverse drug reactions。Clinical Pharmacology & Therapeutics,30(2),239-245。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |